May 2, 2013
|
Issue Brief
States welcome the opportunity to customize their own set of health insurance plans that will offer 10 categories called 'essential health benefits,' but health care providers, consumer groups and patient advocates would prefer a national standard.
February 1, 2012
|
Report
Employee wellness programs can curb costs, but worker protections need to be included in benefit design.
September 28, 2012
|
Program Result
An analysis of the differences in the way 10 health insurance plans in Massachusetts covered the medical costs associated with serious diseases.
March 26, 2013
|
Issue Brief
Early treatment and intervention for mental illness can improve lives and lower related health care costs.
October 1, 2008
|
Journal Article
An examination of two decades of data reveals that health insurance rates for Hispanics have decreased over the past 20 years while rates for non-Hispanics have held roughly steady.
November 1, 2004
|
Program Result
The Harvard University School of Public Health conducted research on the individual health insurance markets in the United States and why people are uninsured, and considered how to redress the problem through public policy.
May 2, 2013
|
Journal Article
Major benefits seen from this Medicaid expansion trial—improved health and well-being; reduced financial strain.
July 1, 2012
|
Issue Brief
The use of patient-facing health information technology (HIT) platforms, such as personal health records (PHRs) and web portals, holds the promise of engaging patients in their own health care with the ultimate purpose of improving overall quality a ...
June 1, 2012
|
Issue Brief
There is little question that the ACA will improve the nongroup and small group insurance markets for everyone in them, including the high-risk population. Yet insurance market reforms, guided by requirements for EHBs, AVs, and other tools provided by the ACA, are and will remain a work in progress.
February 4, 2013
|
Journal Article
The practice of patient-centered care remains in its developmental stages—hampered, in part, by limited evidence of its effectiveness.